Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 15 | 28 | 30 | 37 | 240 |
| Gross Profit | 15 | 28 | 30 | 37 | 240 |
| Operating Expenses | 25,009 | 21,751 | 17,988 | 12,202 | 11,051 |
| Operating Income | -24,994 | -21,723 | -17,958 | -12,165 | -10,811 |
| Other Income | 208 | 228 | 130 | 116 | 116 |
| Pre-tax Income | -24,786 | -21,495 | -17,828 | -12,049 | -10,695 |
| Net Income Continuous | -24,786 | -21,495 | -17,828 | -12,049 | -10,695 |
| Net Income | $-24,786 | $-21,495 | $-17,828 | $-12,049 | $-10,695 |
| EPS Basic Total Ops | -0.25 | -0.22 | -0.19 | -0.13 | -0.12 |
| EPS Basic Continuous Ops | -0.25 | -0.22 | -0.19 | -0.14 | -0.12 |
| EPS Diluted Total Ops | -0.25 | -0.22 | -0.19 | -0.13 | -0.12 |
| EPS Diluted Continuous Ops | -0.25 | -0.22 | -0.19 | -0.14 | -0.12 |
| EBITDA(a) | $-24,578 | $-22,003 | $-17,604 | $-11,536 | $-10,330 |